The trademark application MODYVANZ was filed by Teva Pharmaceutical Industries Ltd., a corporation established under the laws of the State of Israel (the "Applicant"). The application was published for oppositions on July 8, 2021, and it was registered by office on October 15, 2021 without any oppositions.
The application was filed in English (German was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on January 3, 2022. Change of name and address of the trademark registration was recorded on January 3, 2022. Appointment and Replacement of representative of the trademark registration was recorded on January 16, 2022. Change of name and address of the trademark registration was recorded on July 20, 2023.